TARGET N V BIOTECH Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for TARGET N V BIOTECH.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of TARGET N V BIOTECH. TARGET N V BIOTECH is 10% Owner in Monogram Biosciences, Inc. ($VLGC) and 10% Owner in Molecular Templates, Inc. ($MTEM) and 10% Owner in MACROGENICS INC ($MGNX) and 10% Owner in Radius Health, Inc. ($RDUS) and 10% Owner in Esperion Therapeutics, Inc. ($ESPR) and 10% Owner in Cidara Therapeutics, Inc. ($CDTX).
Latest Insider Trading Transactions of TARGET N V BIOTECH
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CDTX, ESPR, MGNX, MTEM, VLGC, RDUS
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 23 2021 | MGNX | MACROGENICS INC | BIOTECH TARGET N V | 10% Owner | Buy | P | 21.74 | 75,000 | 1,630,170 | 6,275,564 | 6.2 M to 6.3 M (+1.21 %) |
Jun 17 2021 | MGNX | MACROGENICS INC | BIOTECH TARGET N V | 10% Owner | Buy | P | 21.04 | 100,000 | 2,104,390 | 6,200,564 | 6.1 M to 6.2 M (+1.64 %) |
Jun 17 2021 | MGNX | MACROGENICS INC | BIOTECH TARGET N V | 10% Owner | Buy | P | 20.53 | 75,000 | 1,539,615 | 6,100,564 | 6 M to 6.1 M (+1.24 %) |
May 07 2021 | ESPR | Esperion Therapeut ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 20.57 | 80,000 | 1,645,632 | 4,177,964 | 4.1 M to 4.2 M (+1.95 %) |
May 07 2021 | ESPR | Esperion Therapeut ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 20.02 | 150,000 | 3,002,850 | 4,097,964 | 3.9 M to 4.1 M (+3.80 %) |
Apr 21 2021 | MTEM | Molecular Template ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 8.08 | 40,852 | 329,941 | 9,542,621 | 9.5 M to 9.5 M (+0.43 %) |
Apr 19 2021 | MTEM | Molecular Template ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 8.62 | 150,000 | 1,292,655 | 9,501,769 | 9.4 M to 9.5 M (+1.60 %) |
Apr 15 2021 | MTEM | Molecular Template ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 8.37 | 150,000 | 1,256,040 | 9,351,769 | 9.2 M to 9.4 M (+1.63 %) |
Apr 15 2021 | MTEM | Molecular Template ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 7.81 | 100,000 | 780,970 | 9,201,769 | 9.1 M to 9.2 M (+1.10 %) |
Apr 13 2021 | MTEM | Molecular Template ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 8.02 | 50,000 | 400,830 | 9,101,769 | 9.1 M to 9.1 M (+0.55 %) |
Apr 13 2021 | MTEM | Molecular Template ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 8.23 | 235,664 | 1,939,633 | 9,051,769 | 8.8 M to 9.1 M (+2.67 %) |
Apr 09 2021 | MTEM | Molecular Template ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 8.22 | 300,000 | 2,466,660 | 8,816,105 | 8.5 M to 8.8 M (+3.52 %) |
Apr 09 2021 | MTEM | Molecular Template ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 8.24 | 200,000 | 1,648,160 | 8,516,105 | 8.3 M to 8.5 M (+2.40 %) |
Apr 07 2021 | MTEM | Molecular Template ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 9.44 | 200,000 | 1,887,100 | 8,316,105 | 8.1 M to 8.3 M (+2.46 %) |
Mar 31 2021 | MTEM | Molecular Template ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 11.45 | 80,000 | 915,848 | 8,116,105 | 8 M to 8.1 M (+1.00 %) |
Feb 25 2021 | MTEM | Molecular Template ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 11.48 | 75,000 | 860,835 | 8,036,105 | 8 M to 8 M (+0.94 %) |
Feb 25 2021 | MTEM | Molecular Template ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 11.29 | 235,004 | 2,653,031 | 7,961,105 | 7.7 M to 8 M (+3.04 %) |
Feb 19 2021 | MTEM | Molecular Template ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 12.65 | 1,185,770 | 14,999,991 | 7,726,101 | 6.5 M to 7.7 M (+18.13 %) |
Feb 01 2021 | MTEM | Molecular Template ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 11.94 | 80,000 | 955,000 | 6,460,331 | 6.4 M to 6.5 M (+1.25 %) |
Dec 11 2020 | MTEM | Molecular Template ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 8.18 | 170,000 | 1,391,416 | 6,380,331 | 6.2 M to 6.4 M (+2.74 %) |
Dec 11 2020 | MTEM | Molecular Template ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 8.39 | 150,000 | 1,258,425 | 6,210,331 | 6.1 M to 6.2 M (+2.48 %) |
Dec 11 2020 | MTEM | Molecular Template ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 8.62 | 125,000 | 1,077,600 | 6,060,331 | 5.9 M to 6.1 M (+2.11 %) |
Nov 12 2020 | MTEM | Molecular Template ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 9.16 | 80,000 | 732,472 | 5,935,331 | 5.9 M to 5.9 M (+1.37 %) |
Nov 12 2020 | MTEM | Molecular Template ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 9.05 | 80,000 | 724,144 | 5,855,331 | 5.8 M to 5.9 M (+1.39 %) |
Nov 04 2020 | ESPR | Esperion Therapeut ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 25.31 | 200,000 | 5,062,120 | 3,947,964 | 3.7 M to 3.9 M (+5.34 %) |
Nov 04 2020 | MTEM | Molecular Template ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 8.83 | 80,000 | 706,312 | 5,229,996 | 5.1 M to 5.2 M (+1.55 %) |
Nov 04 2020 | MTEM | Molecular Template ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 9.40 | 80,000 | 751,688 | 5,149,996 | 5.1 M to 5.1 M (+1.58 %) |
Sep 16 2020 | RDUS | Radius Health, Inc ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 11.69 | 200,000 | 2,338,680 | 7,355,714 | 7.2 M to 7.4 M (+2.79 %) |
Sep 14 2020 | RDUS | Radius Health, Inc ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 11.33 | 199,029 | 2,255,118 | 7,155,714 | 7 M to 7.2 M (+2.86 %) |
Jul 09 2020 | RDUS | Radius Health, Inc ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 13.21 | 25,000 | 330,178 | 6,956,685 | 6.9 M to 7 M (+0.36 %) |
May 04 2020 | RDUS | Radius Health, Inc ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 15.75 | 50,000 | 787,555 | 6,931,685 | 6.9 M to 6.9 M (+0.73 %) |
Jan 27 2020 | ESPR | Esperion Therapeut ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 52.12 | 20,000 | 1,042,398 | 3,747,964 | 3.7 M to 3.7 M (+0.54 %) |
Nov 08 2019 | ESPR | Esperion Therapeut ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 37.30 | 75,000 | 2,797,560 | 3,727,964 | 3.7 M to 3.7 M (+2.05 %) |
Sep 06 2019 | ESPR | Esperion Therapeut ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 33.78 | 80,000 | 2,702,208 | 3,652,964 | 3.6 M to 3.7 M (+2.24 %) |
Jul 25 2019 | ESPR | Esperion Therapeut ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 42.65 | 50,000 | 2,132,565 | 3,572,964 | 3.5 M to 3.6 M (+1.42 %) |
Mar 15 2019 | ESPR | Esperion Therapeut ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 49.89 | 50,000 | 2,494,355 | 3,522,964 | 3.5 M to 3.5 M (+1.44 %) |
Jan 07 2019 | ESPR | Esperion Therapeut ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 41.29 | 80,000 | 3,303,256 | 3,472,964 | 3.4 M to 3.5 M (+2.36 %) |
Dec 26 2018 | ESPR | Esperion Therapeut ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 39.91 | 50,000 | 1,995,725 | 3,392,964 | 3.3 M to 3.4 M (+1.50 %) |
Dec 19 2018 | ESPR | Esperion Therapeut ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 47.73 | 60,000 | 2,864,070 | 3,342,964 | 3.3 M to 3.3 M (+1.83 %) |
Aug 06 2018 | ESPR | Esperion Therapeut ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 46.14 | 50,000 | 2,306,970 | 3,282,964 | 3.2 M to 3.3 M (+1.55 %) |
Jul 13 2018 | ESPR | Esperion Therapeut ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 41.77 | 50,000 | 2,088,300 | 3,232,964 | 3.2 M to 3.2 M (+1.57 %) |
Jul 03 2018 | ESPR | Esperion Therapeut ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 39.48 | 50,000 | 1,973,805 | 3,182,964 | 3.1 M to 3.2 M (+1.60 %) |
Jun 25 2018 | ESPR | Esperion Therapeut ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 38.57 | 60,000 | 2,314,224 | 3,132,964 | 3.1 M to 3.1 M (+1.95 %) |
Jun 11 2018 | ESPR | Esperion Therapeut ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 37.79 | 60,000 | 2,267,292 | 3,072,964 | 3 M to 3.1 M (+1.99 %) |
Jun 07 2018 | ESPR | Esperion Therapeut ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 38.47 | 60,000 | 2,308,440 | 3,012,964 | 3 M to 3 M (+2.03 %) |
May 22 2018 | ESPR | Esperion Therapeut ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 38.77 | 80,000 | 3,101,760 | 2,952,964 | 2.9 M to 3 M (+2.78 %) |
May 22 2018 | ESPR | Esperion Therapeut ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 42.24 | 50,000 | 2,112,010 | 2,872,964 | 2.8 M to 2.9 M (+1.77 %) |
Nov 16 2017 | CDTX | Cidara Therapeutic ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 7.57 | 60,000 | 453,966 | 2,295,272 | 2.2 M to 2.3 M (+2.68 %) |
Dec 31 2003 | VLGC | Monogram Bioscienc ... | BIOTECH TARGET N V | 10% Owner | Option Exercise | C | 0.00 | 242 | 0 | 0 | |
Dec 31 2003 | VLGC | Monogram Bioscienc ... | BIOTECH TARGET N V | 10% Owner | Buy | C | 1.21 | 2,001,074 | 2,421,300 | 2,001,074 | 0 to 2 M |
Page: 1